Companion Animal Diagnostics Market - Global Forecast 2025-2032

The companion animal diagnostics market is undergoing rapid transformation, powered by advances in veterinary care, changing pet owner expectations, and the integration of sophisticated technologies into everyday practice. Senior decision-makers must understand the complexity and growth drivers shaping this sector to inform strategic choices and long-term investments.

Market Snapshot: Companion Animal Diagnostics Market at a Glance

The companion animal diagnostics market grew from USD 3.31 billion in 2024 to USD 3.59 billion in 2025. It is projected to continue expanding at a CAGR of 8.88%, reaching USD 6.55 billion by 2032.

Scope & Segmentation of the Companion Animal Diagnostics Market

This research report delivers comprehensive coverage across the full value chain, encompassing products, technologies, animal species, end-users, and geographic regions relevant to the companion animal diagnostics industry.

• Type of Diagnostic Test: Hematology (blood clotting test, complete blood count), Histopathology (biopsy, cytology), Imaging (ultrasound, X-rays), Molecular diagnostics (DNA sequencing, PCR), Serology (agglutination assay, ELISA test)
• Product Type: Consumables (reagents, test kits), Instruments/Analyzers (clinical chemistry analyzers, hematology analyzers, immunodiagnostic analyzers, molecular diagnostic analyzers)
• Animal Type: Birds, cats, dogs, guinea pigs, horses
• End-User: In-house testing facilities (animal shelters, pet owners), research laboratories, veterinary hospitals and clinics
• Application: Endocrinology testing, genetic testing, infectious disease diagnostics, nutritional analysis, oncology, therapeutic drug monitoring, toxicology testing
• Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland), Middle East (United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel), Africa (South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Leading Companies: Bio-Rad Laboratories, Thermo Fisher Scientific, Agrolabo, Biogal Galed Labs, BioMérieux, BioNote, Demeditec Diagnostics, Eurofins Technologies, Fassisi, FUJIFILM Holdings, IDEXX Laboratories, IDvet, Mars, Neogen Corporation, Nisseiken, Qiagen, Randox Laboratories, Shenzhen Bioeasy Biotechnology, Shenzhen Mindray Animal Medical Technology, SKYER, Skyla, Vimian Group, Virbac, Zoetis

Key Takeaways: Strategic Insights for Decision-Makers

• Technological progress—including advanced imaging, molecular assays, and point-of-care platforms—is reshaping veterinary diagnostics, enabling earlier and more accurate disease detection for a wide range of species.
• Industry dynamics reflect increased demand for preventive and personalized diagnostic services, as pet owners expect standards comparable to those in human healthcare.
• Regulatory frameworks are evolving to promote harmonization and streamline approval processes, fostering innovation and ensuring better market access across regions.
• Strategic partnerships among manufacturers, research institutions, and veterinary software developers are accelerating the translation of novel diagnostics into routine clinical use and improving data integration.
• Regional markets display varying levels of adoption; the Americas show high uptake of advanced platforms, while Asia-Pacific benefits from local investment in manufacturing and technology transfer initiatives.
• Resilient supply chains have become a competitive advantage, particularly as companies diversify sourcing and localize production to manage regulatory and geopolitical uncertainty.

Impact of United States Tariff Updates on Supply Chains

Recently updated tariff measures in the United States have influenced the companion animal diagnostics supply chain. Manufacturers are reassessing pricing and sourcing strategies in response to increased import costs for instruments and reagents. Administrative resources are required to ensure compliance with shifting trade policies, and many companies are investing in regional supplier relationships to protect supply continuity and mitigate risk exposure. These changes highlight the importance of robust supply chain planning and strategic agility for market participants.

Methodology & Data Sources

This report is based on primary interviews with veterinary experts, laboratory directors, and market leaders, complemented by in-depth secondary analysis of regulatory submissions, industry publications, and supplier disclosures. Triangulation and expert validation were used to ensure data accuracy and comprehensive insight.

Why This Report Matters

• Offers clarity on segmentation trends and actionable guidance for aligning product and investment strategies with evolving clinical requirements.
• Delivers a thorough understanding of risk and opportunity across regions, technologies, and regulatory environments.
• Enables senior decision-makers to anticipate shifts in market dynamics and make informed decisions on partnerships and supply chain strategies.

Conclusion

The companion animal diagnostics market is evolving rapidly, with technology, clinical needs, and regulatory frameworks all driving change. Stakeholders who act decisively and adapt to shifting conditions are positioned to lead in delivering next-generation veterinary diagnostic solutions.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.